Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does elevated homocysteine with high B12 and folate reflect impaired homocysteine disposal rather than a single nutrient deficiency?

Elevated homocysteine in this setting can indicate reduced homocysteine remethylation or transsulfuration efficiency, but it does not prove an overt single-nutrient deficiency.

PlausibleAugust 21, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Homocysteine above optimal despite high serum vitamin B12 and optimal serum folate can reflect reduced homocysteine remethylation or transsulfuration efficiency rather than an overt single-nutrient deficiency.

laying out figure…
1 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a biochemical pattern where homocysteine remains above optimal even though serum B12 is high and folate appears adequate. The mechanism framing suggests this can happen when homocysteine disposal through remethylation or B6-dependent transsulfuration is less efficient. It also emphasizes that the signal is nonspecific and needs broader functional and competing-cause assessment.

Verified conclusion

Elevated homocysteine in a 71-year-old man despite high total serum B12 and apparently optimal folate is a meaningful but nonspecific metabolic signal. It can be compatible with impaired homocysteine disposal, but does not identify a single cause or prove an overt vitamin deficiency.

Mechanistic interpretation

  • Remethylation is plausible: methionine synthase converts homocysteine to methionine using methylcobalamin and 5-methyltetrahydrofolate. Impaired intracellular cobalamin handling, methionine-synthase activity or reductive reactivation, and reduced MTHFR-mediated generation of 5-methyltetrahydrofolate can reduce this flux despite non-low circulating B12 and folate.
  • Transsulfuration is also plausible: cystathionine β-synthase and cystathionine γ-lyase require pyridoxal-5′-phosphate (PLP, active B6). B6 deficiency is associated with accumulation of homocysteine and cystathionine, particularly after methionine loading, consistent with limited transsulfuration capacity.

Clinical interpretation and testing

  • High total B12 does not ensure adequate cellular B12 function, especially with supplementation. Conversely, serum folate largely reflects circulating/recent status rather than proving normal intracellular one-carbon flux.
  • Homocysteine is influenced by renal impairment, hypothyroidism, age, medications, alcohol exposure, genetic variation, and nutritional factors. Kidney disease is particularly important because it can elevate homocysteine and MMA independently.
  • A useful targeted assessment includes creatinine/eGFR, MMA interpreted alongside renal function, PLP/B6 status, thyroid testing, CBC, and medication review. Holotranscobalamin may add information when total B12 is discordant with clinical suspicion.

Bottom line

  • The claim is scientifically supported overall: this pattern can reflect reduced remethylation or B6-dependent transsulfuration efficiency rather than an overt isolated nutrient deficiency, but it should prompt functional and competing-cause assessment rather than assignment of a specific pathway defect from homocysteine alone.

References

  1. Guidelines for Investigation and Management of Vitamin B12 and ... — hey.nhs.uk ↗
  2. [PDF] Test Ordering Guidelines for Suspected Vitamin B12 and Folate ... — documents.cap.org ↗
  3. Guidelines for diagnosis and management of the cobalamin ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  4. Vitamin B12 , folate, and the methionine remethylation cycle ... — pubmed.ncbi.nlm.nih.gov ↗
  5. Homocysteine—a retrospective and prospective appraisal — frontiersin.org ↗
  6. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  7. Vitamin B-6 and Homocysteine Metabolism — content-assets.jci.org ↗
  8. Assessing biomarker status of vitamin B12 in the laboratory: no simple solution - Catherine F Hughes, Helene McNulty, 2018 — journals.sagepub.com ↗
  9. Vitamin B12 status in health and disease: a critical review. ... — tandfonline.com ↗
  10. Guidelines for the diagnosis and treatment of cobalamin and folate disorders — onlinelibrary.wiley.com ↗
  11. Diagnosis, Treatment and Long-Term Management of Vitamin ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→